The Brigham and Dana-Farber Board Review in Hematology and Oncology 2018 
2025 Hematology and Oncology Best Practices- On-Demand Full Session Course
$145.00
This Product is shared via google drive download link, So please share your correct Gmail id while placing the order .Please note that there are no CME points or certificate associated with this course Samples for Courses Can be found here : Free Samples Here!
Target Audience
This course is ideal for physicians preparing to take the Hematology and Oncology certification exams as well as individuals desiring a comprehensive review of hematology and medical oncology standards of care.
Learning Objectives
At the conclusion of the Hematology and Oncology Best Practices course, the successful learner will be able to:
Hematology
- Understand both established information and recent clinical advances in immunohematology, bone marrow transplantation, and hematopoietic growth factors
- Understand both established information and recent clinical advances in coagulopathies, anticoagulant and thrombolytic therapies
- Understand blood and marrow morphology and hematopathology
- Understand red cell disorders
Hematologic Malignancies
- Understand the most recent advances in the pharmacology and toxicology of anti-neoplastic drugs
- Be familiar with the diagnosis, evaluation, and management of hematologic malignancies
- Identify strategies for taking the board examinations
Oncology
- Understand the epidemiology of malignant diseases and management of the medical complications of malignancy
- Comprehend the principles of management of gynecologic and other genito-urinary malignancies
- Identify the latest advances in cancers of the lung, the breast, and the gastrointestinal tract
- Recognize principles of new developments in biologic therapy of cancer
Program Agenda
COURSE CONTENT
This online course is divided into 3 modules:
2025 HEMONC Best Practices Course Syllabus FULL SESSION COURSE.pdf
Hematology Sessions:
- Session 0 (Hematology): Anemias, Porpyrias, Red Cell Enzymes, Clotting, Cellular Morphology and Liquid Biopsies (4.00 hours)
- Session 1: Iron Deficiency, Hemoglobinopathies, Hemolytic Anemia, Hemophilias, Transfusion Medicine, Hematologic Complications of Pregnancy and Platelet Alloimmunization (9.00 hours)
- Session 2: Sickling Disorders, Consumptive Thrombohemorrhagic Disorders, Bone Marrow Failure, White Cell Disorders, DIC, HIT, VITT, Ischemic Limb Gangrene, ABO Incompatibility, ITP Drug-Induced Thrombocytopenia and Hematopoietic Transplantation (8.75 hours)
Hematologic Malignancies Sessions:
- Session 3: Lymphomas, Multiple Myeloma, MGUS, ALL, CML, Plasma Cell Disorders, Myelodysplasia, Waldenstrom’s Macroglobulinemia and Palliative Care (9.25 hours)
- Session 4: AML, Bone Marrow Transplantation, Myeloproliferative Neoplasms, CLL, Pharmacology and T Cell Therapies (9.25 hours)
Medical Oncology Sessions:
- Session 5: Head/Neck Cancer, Familial Cancer Syndromes, Lung Cancer, Breast Cancer, Lung Cancer, Neuro-Oncology and Endocrine Malignancies (9.00 hours)
- Session 6: Renal Cell, Prostate, Bladder, Testicular, Ovarian, Endometrial Tumors, Melanoma, Carcinoid Tumors and Mesothelioma (10.00 hours)
- Session 7: GI Oncology, Pancreatic Cancer and Sarcomas (6.75 hours)
Related products
Critical Care \ Emergency medicine
Hematology / Oncology
11th Annual Hematology and Medical Oncology Board Review: Contemporary Practice – On Demand
